Show side menu

RES-KIT: Point-of-care kit for the detection of antimicrobial resistance

Starting date: 23/07/2020 End date: 22/01/2022

Financing entities:

The general objective of the project is to demonstrate the feasibility of implementing a rapid test kit (RES-KIT) for bacterial quantification, identification, and antimicrobial susceptibility test (AST) with our innovative microfluidic technology.

This general objective can be divided in the next sub-objectives:

  1. To develop a prototype of the instrument and the cartridge capable of performing the assay automatically from a real sample.
  2. To demonstrate the feasibility of scaling up (mass produce) all
    the components of the system
  3. To perfom a clinical evaluation of the kit with real cases and a “usability” test in view of its commercialization.

Cystitis in pets will be the first application to explore.